Colombia seeks to attract medtech companies for clinical trials

The government of Colombia, in collaboration with the clinical development firm Interventional Concepts, is actively seeking to promote Colombia as a destination for early-stage clinical trials. Between 1995 and 2013, 738 clinical trials were conducted in the country. Although approximately 90 percent of those studies were in the pharmaceutical space, a growing number are being performed in the medical technology field for companies such as Avinger, Kona Medical, and InterValve. According to the government/industry alliance, some of the key benefits of doing clinical work in Colombia are:

  • High enrollment rates
  • Competitive costs
  • Motivated, bi-lingual investigators
  • Fast and predictable regulatory pathway
  • Well-developed healthcare infrastructure and business environment for clinical trials
  • Fast product importation
  • Over 120 government-certified research sites with more than 20 years experience and quality standards comparable to the US

For more information, see the alliance press release and presentation.

This entry was posted in Updates. Bookmark the permalink.